The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

Independent sellers on Amazon's marketplace are reporting an increase in fraudulent returns that they say is cutting into ...

The ticketing software industry is constantly advancing, driven by ongoing innovations and developments. The event ticketing ...

In a report released today, Hamed Khorsand from BWS Financial maintained a Hold rating on Hawkins (HWKN – Research Report), with a price target ...

If you’ve been keeping an eye on the cryptocurrency community, it’s hard to ignore the buzz surrounding Qarden’s upcoming ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

Q4 2024 Earnings Conference Call January 31, 2025 8:00 AM ETCompany ParticipantsGreg Riddle - IRMark Costa - Board ...

A series of Target 7 Investigations have prompted legislative action on several key issues affecting New Mexico residents.

Exxon Mobil Corporation today announced fourth-quarter 2024 earnings of $7.6 billion, or $1.72 per share assuming dilution. Cash flow from operating activities was $12.2 billion a ...

Annual results Kaufman & Broad SA Kaufman & Broad SA: 2024 Annual results 30-Jan-2025 / 18:40 CET/CEST Dissemination of a French Regulatory News, transmitted by ...

In 2025, it's easier than ever to build an AI chatbot. We explain how to build a chatbot from scratch in 7 steps, without ...

Looking at the largest US startup funding rounds from January 2025, leveraging data from CrunchBase, we’ve analyzed the most significant venture capital deals of the month. Beyond the raw funding ...